JP2006143751A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006143751A5 JP2006143751A5 JP2006058747A JP2006058747A JP2006143751A5 JP 2006143751 A5 JP2006143751 A5 JP 2006143751A5 JP 2006058747 A JP2006058747 A JP 2006058747A JP 2006058747 A JP2006058747 A JP 2006058747A JP 2006143751 A5 JP2006143751 A5 JP 2006143751A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- mammal
- medicament
- manufacture
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37205802P | 2002-04-12 | 2002-04-12 | |
| US40549502P | 2002-08-23 | 2002-08-23 | |
| US43460702P | 2002-12-18 | 2002-12-18 | |
| US10/410,991 US6953787B2 (en) | 2002-04-12 | 2003-04-10 | 5HT2C receptor modulators |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003583332A Division JP4155926B2 (ja) | 2002-04-12 | 2003-04-11 | ５ｈｔ２ｃレセプター修飾因子 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008202412A Division JP4966929B2 (ja) | 2002-04-12 | 2008-08-05 | ５ｈｔ２ｃレセプター修飾因子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006143751A JP2006143751A (ja) | 2006-06-08 |
| JP2006143751A5 true JP2006143751A5 (enExample) | 2008-09-18 |
| JP4191741B2 JP4191741B2 (ja) | 2008-12-03 |
Family
ID=29255581
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003583332A Expired - Lifetime JP4155926B2 (ja) | 2002-04-12 | 2003-04-11 | ５ｈｔ２ｃレセプター修飾因子 |
| JP2006058747A Expired - Lifetime JP4191741B2 (ja) | 2002-04-12 | 2006-03-03 | ５ｈｔ２ｃレセプター修飾因子 |
| JP2008202412A Expired - Lifetime JP4966929B2 (ja) | 2002-04-12 | 2008-08-05 | ５ｈｔ２ｃレセプター修飾因子 |
| JP2011201117A Expired - Lifetime JP5602116B2 (ja) | 2002-04-12 | 2011-09-14 | ５ｈｔ２ｃレセプター修飾因子 |
| JP2012211059A Withdrawn JP2013018780A (ja) | 2002-04-12 | 2012-09-25 | ５ｈｔ２ｃレセプター修飾因子 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003583332A Expired - Lifetime JP4155926B2 (ja) | 2002-04-12 | 2003-04-11 | ５ｈｔ２ｃレセプター修飾因子 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008202412A Expired - Lifetime JP4966929B2 (ja) | 2002-04-12 | 2008-08-05 | ５ｈｔ２ｃレセプター修飾因子 |
| JP2011201117A Expired - Lifetime JP5602116B2 (ja) | 2002-04-12 | 2011-09-14 | ５ｈｔ２ｃレセプター修飾因子 |
| JP2012211059A Withdrawn JP2013018780A (ja) | 2002-04-12 | 2012-09-25 | ５ｈｔ２ｃレセプター修飾因子 |
Country Status (28)
| Country | Link |
|---|---|
| US (11) | US6953787B2 (enExample) |
| EP (4) | EP2363394A1 (enExample) |
| JP (5) | JP4155926B2 (enExample) |
| KR (3) | KR100908167B1 (enExample) |
| CN (5) | CN101486678B (enExample) |
| AT (1) | ATE294781T1 (enExample) |
| AU (1) | AU2003221866B2 (enExample) |
| BR (2) | BRPI0309303B8 (enExample) |
| CA (1) | CA2481723C (enExample) |
| CR (2) | CR7503A (enExample) |
| DE (1) | DE60300610T2 (enExample) |
| DK (1) | DK1411881T3 (enExample) |
| ES (2) | ES2242165T3 (enExample) |
| GE (1) | GEP20074197B (enExample) |
| IL (1) | IL164162A0 (enExample) |
| IS (1) | IS2134B (enExample) |
| MX (1) | MXPA04009965A (enExample) |
| MY (1) | MY141476A (enExample) |
| NO (1) | NO323528B1 (enExample) |
| NZ (1) | NZ535381A (enExample) |
| PL (4) | PL219017B1 (enExample) |
| PT (1) | PT1411881E (enExample) |
| RU (1) | RU2317982C2 (enExample) |
| SI (1) | SI1411881T1 (enExample) |
| TW (1) | TWI252105B (enExample) |
| UA (1) | UA77788C2 (enExample) |
| WO (1) | WO2003086306A2 (enExample) |
| ZA (1) | ZA200408506B (enExample) |
Families Citing this family (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8478824B2 (en) * | 2002-02-05 | 2013-07-02 | Portauthority Technologies Inc. | Apparatus and method for controlling unauthorized dissemination of electronic mail |
| SE0200968D0 (sv) * | 2002-03-26 | 2002-03-26 | Lars Baltzer | Novel polypeptide scaffolds and use thereof |
| US6953787B2 (en) | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
| US7595311B2 (en) | 2002-05-24 | 2009-09-29 | Exelixis, Inc. | Azepinoindole derivatives as pharmaceutical agents |
| TWI329111B (en) | 2002-05-24 | 2010-08-21 | X Ceptor Therapeutics Inc | Azepinoindole and pyridoindole derivatives as pharmaceutical agents |
| WO2004056369A1 (en) | 2002-12-20 | 2004-07-08 | Glaxo Group Limited | Benzo ‘ d!azepine derivatives for the treatment of neurological disorders |
| NZ578503A (en) * | 2003-06-17 | 2011-02-25 | Arena Pharm Inc | Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases |
| WO2005019179A2 (en) * | 2003-06-17 | 2005-03-03 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases |
| TW200510324A (en) * | 2003-08-11 | 2005-03-16 | Lilly Co Eli | 6-(2,2,2-trifluoroethylamino)-7-chiloro-2, 3, 4, 5-tetrahydro-1h-benzo[d]azepine as a 5-ht2c receptor agonist |
| WO2005042490A1 (en) * | 2003-10-22 | 2005-05-12 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
| US20080009478A1 (en) * | 2003-10-22 | 2008-01-10 | Arena Pharmaceuticals, Inc. | Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2c Receptor Associated Diseases |
| BRPI0415842A (pt) * | 2003-10-23 | 2007-01-02 | Hoffmann La Roche | derivativos de benzapepina como inibidores de mao-b |
| NZ549009A (en) | 2004-02-25 | 2010-08-27 | Lilly Co Eli | 6-substituted 2,3,4,5-tetrahydro-1H-benzo[D]azepines as 5-HT2C receptor agonists |
| US8685924B2 (en) | 2004-08-25 | 2014-04-01 | Takeda Pharmaceutical Company Limited | Preventives/remedies for stress urinary incontinence and method of screening the same |
| WO2006028961A2 (en) * | 2004-09-03 | 2006-03-16 | Athersys, Inc. | Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators |
| US7528175B2 (en) * | 2004-10-08 | 2009-05-05 | Inverseon, Inc. | Method of treating airway diseases with beta-adrenergic inverse agonists |
| WO2006044762A2 (en) * | 2004-10-15 | 2006-04-27 | Bayer Pharmaceuticals Corporation | Tetrahydro-5h-pyrimido[4,5-d]azepine derivatives useful for the treatment of diseases associated with the 5-ht2c receptor |
| EP1836183A2 (en) * | 2004-12-13 | 2007-09-26 | Galileo Pharmaceuticals, Inc. | Spiro derivatives as lipoxygenase inhibitors |
| WO2006069363A2 (en) | 2004-12-21 | 2006-06-29 | Arena Pharmaceuticals, Inc. | Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride |
| DK1833473T3 (da) * | 2004-12-23 | 2010-01-11 | Arena Pharm Inc | 5HT2C-Receptormodulator-sammensætninger og metoder for anvendelse |
| AU2012201515B2 (en) * | 2004-12-23 | 2015-01-29 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulator compositions and methods of use |
| EP1869000A1 (en) * | 2005-03-31 | 2007-12-26 | Pfizer Products Incorporated | Cyclopentapyridine and tetrahydroquinoline derivatives |
| US20090203750A1 (en) * | 2005-08-24 | 2009-08-13 | Alan Kozikowski | 5-HT2C Receptor Agonists as Anorectic Agents |
| ATE437859T1 (de) * | 2005-09-01 | 2009-08-15 | Lilly Co Eli | 6-substituierte- 2,3,4,5-tetrahydro-1h- benzoädüazepine als 5-ht2c-rezeptoragonisten |
| US20080269196A1 (en) | 2005-09-01 | 2008-10-30 | Karin Briner | 6-Arylalkylamino-2,3,4,5-Tetrahydro-1H-Benzo[D]Azepines as 5-Ht2c Receptor Agonists |
| EP1924578B1 (en) | 2005-09-01 | 2013-11-06 | Eli Lilly And Company | 6-N-LINKED HETEROCYCLE-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS |
| SI1924560T1 (sl) * | 2005-09-01 | 2010-01-29 | Lilly Co Eli | 6-substituirani-2,3,4,5-tetrahidro-1h-benzo(d)azepini kot agonisti 5-ht2c receptorja |
| DE102006009004A1 (de) * | 2006-02-23 | 2007-09-06 | Sustech Gmbh & Co. Kg | Multifunktionelle sternförmige Präpolymere, deren Herstellung und Verwendung |
| EP2001852A2 (en) | 2006-04-03 | 2008-12-17 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto |
| US8158617B2 (en) | 2006-05-16 | 2012-04-17 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound and use thereof |
| WO2007140213A1 (en) * | 2006-05-26 | 2007-12-06 | Forest Laboratories Holdings Limited | Pyridoazepine derivatives |
| US20070293475A1 (en) * | 2006-06-20 | 2007-12-20 | Alcon Manufacturing Ltd. | Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma |
| MX2009000508A (es) * | 2006-07-14 | 2009-01-27 | Pfizer Prod Inc | Sal tartrato de (7s)-7-[(5-fluoro-2-metil-bencil)oxi]-2-[(2r)-2-me tilpiperazin-1-il]-6,7-dihidro-5h-ciclopenta[b]piridina. |
| EP2099743B1 (en) * | 2006-12-05 | 2014-08-27 | Arena Pharmaceuticals, Inc. | Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof |
| US20100197908A1 (en) * | 2006-12-11 | 2010-08-05 | Boehringer Ingelheim International Gmbh | Pyridazine Derivatives with MCH Antagonistic Activity and Medicaments Comprising These Compounds |
| WO2009051747A1 (en) * | 2007-10-15 | 2009-04-23 | Concert Pharmaceuticals, Inc. | Deuterated lorcaserin |
| JP5520051B2 (ja) | 2007-11-15 | 2014-06-11 | 武田薬品工業株式会社 | 縮合ピリジン誘導体およびその用途 |
| JP5491421B2 (ja) * | 2008-03-04 | 2014-05-14 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ５−ｈｔ２ｃアゴニストである（ｒ）−８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンゾアゼピンに関連する中間体の調製のためのプロセス |
| CA2719721C (en) | 2008-03-26 | 2012-12-18 | Daiichi Sankyo Company, Limited | Tetrahydroisoquinoline derivative |
| EP2246331A1 (en) * | 2009-04-24 | 2010-11-03 | Westfälische Wilhelms-Universität Münster | NR2B-selective NMDA-receptor antagonists |
| WO2010148207A2 (en) | 2009-06-18 | 2010-12-23 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-ht2c receptor agonists |
| EP2510949A4 (en) | 2009-12-11 | 2013-11-13 | Astellas Pharma Inc | THERAPEUTICS FOR FIBROMYALGIA |
| WO2011097336A2 (en) | 2010-02-04 | 2011-08-11 | The Board Of Trustees Of The University Of Illinois | Highly selective 5-ht(2c) receptor agonists having antagonist activity at the 5-ht(2b) receptor |
| EP2539364A1 (en) | 2010-02-26 | 2013-01-02 | Novo Nordisk A/S | Peptides for treatment of obesity |
| BR112012021231A2 (pt) | 2010-02-26 | 2015-09-08 | Basf Plant Science Co Gmbh | método para acentuar o rendimento em plantas, planta, construto, uso de um construto, método para a produção de uma planta transgênica, partes coletáveis de uma planta, produtos derivados de uma planta, uso de um ácido nucleíco e método para a produção de um produto |
| US20110269744A1 (en) * | 2010-03-12 | 2011-11-03 | Astellas Pharma Inc. | Benzazepine Compound |
| WO2011117415A1 (en) | 2010-03-26 | 2011-09-29 | Novo Nordisk A/S | Novel glucagon analogues |
| WO2011153206A1 (en) * | 2010-06-02 | 2011-12-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-ht2c receptor agonists |
| KR20140091458A (ko) | 2010-09-01 | 2014-07-21 | 아레나 파마슈티칼스, 인크. | 신장 손상을 갖는 개체에 대한 로카세린의 투여 |
| CN103189360A (zh) * | 2010-09-01 | 2013-07-03 | 艾尼纳制药公司 | 5-ht2c激动剂的非吸湿性盐 |
| CN107669687A (zh) * | 2010-09-01 | 2018-02-09 | 艾尼纳制药公司 | 用于体重控制的5‑ht2c激动剂的调节释放剂型 |
| US20130267500A1 (en) | 2010-09-01 | 2013-10-10 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level |
| SG10201506873WA (en) * | 2010-09-01 | 2015-10-29 | Arena Pharm Inc | Fast-dissolve dosage forms of 5-ht2c agonists |
| CA2808909A1 (en) * | 2010-09-01 | 2012-03-08 | Arena Pharmaceuticals, Inc. | Salts of lorcaserin with optically active acids |
| CN103596583B (zh) | 2011-03-28 | 2016-07-27 | 诺沃—诺迪斯克有限公司 | 新型胰高血糖素类似物 |
| US8541368B2 (en) | 2011-09-23 | 2013-09-24 | Novo Nordisk A/S | Glucagon analogues |
| CN102895233B (zh) * | 2012-09-04 | 2015-06-24 | 苏州大学 | 苯并氮杂卓类化合物在制备预防或治疗癫痫的药物中的应用 |
| JP2015534563A (ja) | 2012-10-09 | 2015-12-03 | アリーナ ファーマシューティカルズ， インコーポレイテッド | 体重管理の方法 |
| WO2014060575A2 (en) | 2012-10-19 | 2014-04-24 | Medichem S.A. | Process for the enantioselective synthesis of a tetrahydrobenzazepine compound |
| AU2014255608B2 (en) | 2013-04-18 | 2018-01-25 | Novo Nordisk A/S | Stable, protracted GLP-1/glucagon receptor co-agonists for medical use |
| EP2999692A1 (en) | 2013-05-20 | 2016-03-30 | LEK Pharmaceuticals d.d. | Novel synthetic processes to 8-chloro-3-benzo[d]azepine via friedel-crafts alkylation of olefin |
| CN105517994A (zh) | 2013-06-21 | 2016-04-20 | 斯洛文尼亚莱柯制药股份有限公司 | 通过α-取代的苯乙烯类的不对称还原制备手性1-甲基-2，3，4，5-1H-苯并二氮杂*类 |
| WO2015007897A1 (en) * | 2013-07-19 | 2015-01-22 | Lek Pharmaceuticals D.D. | Method of racemisation of undesired enantiomers |
| WO2015066344A1 (en) | 2013-11-01 | 2015-05-07 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
| EP2868656A1 (en) | 2013-11-05 | 2015-05-06 | LEK Pharmaceuticals d.d. | Stabilized amorphous lorcaserin hydrochloride |
| WO2015096119A1 (zh) * | 2013-12-27 | 2015-07-02 | 杭州普晒医药科技有限公司 | 氯卡色林盐及其晶体、其制备方法和用途 |
| CN105228986B (zh) | 2014-04-21 | 2017-11-07 | 杭州普晒医药科技有限公司 | 一种氯卡色林共晶及其制备方法、药物组合物和用途 |
| EP3151852A1 (en) | 2014-06-04 | 2017-04-12 | Novo Nordisk A/S | Glp-1/glucagon receptor co-agonists for medical use |
| TW201618787A (zh) | 2014-10-30 | 2016-06-01 | 艾尼納製藥公司 | 組合物及方法 |
| PL3250549T3 (pl) | 2015-01-29 | 2021-12-13 | The Board Of Trustees Of The University Of Illinois | Cyklopropylometanoaminy jako selektywni agoniści receptora 5-HT(2C) |
| CN108137508B (zh) * | 2015-07-31 | 2021-08-27 | 艾尼纳制药公司 | 5-ht2c受体激动剂和组合物及使用方法 |
| DE102015117882A1 (de) * | 2015-10-21 | 2017-04-27 | Mehrdad Ghashghaeinia | Pharmazeutische Zusammensetzung |
| EP3210975A1 (en) | 2016-02-24 | 2017-08-30 | Enantia, S.L. | Cocrystals of lorcaserin |
| JP6725838B2 (ja) * | 2016-09-16 | 2020-07-22 | 富士通クライアントコンピューティング株式会社 | ヒンジ、スタンド装置、及び、電子機器 |
| CA3055652A1 (en) | 2017-03-15 | 2018-09-20 | Silverback Therapeutics, Inc. | Benzazepine compounds, conjugates, and uses thereof |
| WO2018167194A1 (en) | 2017-03-15 | 2018-09-20 | Novo Nordisk A/S | Bicyclic compounds capable of binding to melanocortin 4 receptor |
| US20210052600A1 (en) | 2017-12-27 | 2021-02-25 | Takeda Pharmaceutical Company Limited | Therapeutic agents for stress urinary incontinence and incotinence of feces |
| US20210221867A1 (en) | 2018-05-15 | 2021-07-22 | Novo Nordisk A/S | Compounds Capable of Binding to Melanocortin 4 Receptor |
| KR20190132711A (ko) | 2018-05-21 | 2019-11-29 | 주식회사 다림바이오텍 | 비만 예방 또는 치료용 약학 조성물 |
| KR20190133482A (ko) | 2018-05-23 | 2019-12-03 | 동국제약 주식회사 | 흰강낭콩 및 아위버섯 추출물을 함유하는 항비만 또는 체지방 감소용 조성물 |
| WO2020053414A1 (en) | 2018-09-14 | 2020-03-19 | Novo Nordisk A/S | Bicyclic compounds capable of acting as melanocortin 4 receptor agonists |
| WO2020072675A1 (en) | 2018-10-02 | 2020-04-09 | Northwestern University | Beta-carbolines as positive allosteric modulators of the human serotonin receptor 2c (5-ht2c) |
| JP7735291B2 (ja) | 2020-02-21 | 2025-09-08 | エーアールエス ファーマシューティカルズ、インコーポレイテッド | ネクチン－４抗体コンジュゲートおよびその使用 |
| KR20230047361A (ko) | 2020-07-01 | 2023-04-07 | 아르스 파마슈티컬스 인크. | 항-asgr1 항체 접합체 및 이의 용도 |
| WO2025252661A1 (en) | 2024-06-03 | 2025-12-11 | Immunic Ag | Reducing body weight and/or induction of satiety by triazolo compounds |
Family Cites Families (81)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US372058A (en) | 1887-10-25 | William m | ||
| US434607A (en) | 1890-08-19 | Barrel-washing machine | ||
| US405495A (en) | 1889-06-18 | Picker-staff connection for looms | ||
| CH498122A (de) | 1968-02-09 | 1970-10-31 | Geigy Ag J R | Verfahren zur Herstellung eines neuen Tetrahydroazepinderivates |
| CH481110A (de) | 1967-02-17 | 1969-11-15 | Geigy Ag J R | Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen |
| CH500194A (de) | 1968-02-15 | 1970-12-15 | Ciba Geigy Ag | Verfahren zur Herstellung von Tetrahydroazepinderivaten |
| US4233217A (en) | 1968-03-11 | 1980-11-11 | Pennwalt Corporation | Substituted 1,2,4,5-tetrahydro-3H, 3 benzazepines |
| GB1268243A (en) | 1968-03-11 | 1972-03-22 | Wallace & Tiernan Inc | 0,2,4,5,-tetrahydro-3h,3-benzazepines |
| FR7736M (enExample) | 1968-09-02 | 1970-03-09 | ||
| US3592523A (en) * | 1969-05-19 | 1971-07-13 | Ncr Co | Angle multiplier apparatus |
| US3716639A (en) | 1970-03-11 | 1973-02-13 | Ciba Geigy Corp | Anorexigenic tetrahydrobenzazepines |
| US3795683A (en) | 1970-08-19 | 1974-03-05 | Hoffmann La Roche | 2,3,4,5-tetrahydro-1h-3-benzazepines |
| LU65954A1 (enExample) * | 1972-08-25 | 1974-03-07 | ||
| US4210749A (en) * | 1974-11-12 | 1980-07-01 | Pennwalt Corporation | Substituted 1,2,4,5-tetrahydro-3H,3 benzazepines |
| US4111957A (en) | 1977-02-02 | 1978-09-05 | Smithkline Corporation | Substituted 1-thienyl and furyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds |
| US4108989A (en) | 1977-04-01 | 1978-08-22 | Smithkline Corporation | 2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diones |
| CA1090797A (en) | 1978-06-20 | 1980-12-02 | Kenneth G. Holden | Substituted 1-thienyl and furyl-2,3,4,5-tetrahydro-1h- 3-benzazepine compounds |
| AU515236B2 (en) | 1978-06-26 | 1981-03-26 | Smithkline Corporation | Substituted-1-thienyl and furyl-2,3,4,5-tetrahydro-14-3 benzazepine derivatives |
| ZA792785B (en) | 1978-07-07 | 1980-08-27 | Smithkline Corp | Mercapto substituted-2,3,4,5-tetrahydro-1h-3-benzazepines |
| EP0080779B1 (en) | 1981-11-27 | 1986-07-16 | Smithkline Beckman Corporation | 3-benzazepines as alpha-2 antagonists |
| FR2525603A1 (fr) | 1982-04-27 | 1983-10-28 | Adir | Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique |
| US4988690A (en) | 1982-06-14 | 1991-01-29 | Hoechst-Roussel Pharmaceuticals Inc. | 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines and anti-depressant use thereof |
| US4541954A (en) | 1984-09-05 | 1985-09-17 | Smithkline Beckman Corporation | Method for preparing 6-chloro-N-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine |
| US4762845A (en) | 1986-05-21 | 1988-08-09 | Abbott Laboratories | 7-(3-Substituted imino-1-pyrrolidinyl)-quinolone-3-carboxylic acids |
| EP0285287A3 (en) | 1987-03-23 | 1990-08-16 | Smithkline Beecham Corporation | 3-benzazepine compounds for use in treating gastrointestinal motility disorders |
| US5015639A (en) * | 1987-03-27 | 1991-05-14 | Schering Corporation | Substituted benzazepines, their preparation and pharmaceutical compositions containing them |
| US5247080A (en) * | 1987-03-27 | 1993-09-21 | Schering Corporation | Substituted benzazepines useful as intermediates for producing pharmaceutically active compounds |
| PH27337A (en) | 1987-03-27 | 1993-06-08 | Schering Corp | Substituted benzazepines their preparation and pharmaceutical compositions containing them |
| AU1700688A (en) | 1987-04-09 | 1988-11-04 | Smithkline Beckman Corporation | Sulfinyl and sulfonyl substituted 3-benzazepines |
| US5105639A (en) * | 1989-02-23 | 1992-04-21 | Spiro America Inc. | Apparatus for forming spiral pipe |
| US5422355A (en) * | 1989-06-02 | 1995-06-06 | John Wyeth & Brother, Limited | Composition for treating depression with (N-heteroaryl)alkylamines |
| US5178786A (en) * | 1989-08-04 | 1993-01-12 | The Lubrizol Corporation | Corrosion-inhibiting compositions and functional fluids containing same |
| ZA914536B (en) | 1990-06-15 | 1992-03-25 | Schering Corp | 8-lower alkyl-5-cycloalkyl or 5-cycloakenyl substituted benzazepines and pharmaceutical compositions containing them |
| US5275915A (en) * | 1991-06-05 | 1994-01-04 | Dainippon Ink And Chemicals, Inc. | Developer for light-sensitive material |
| CA2110575A1 (en) | 1991-06-21 | 1993-01-07 | John Gerard Ward | Use of tetrahydrobenzazepine derivatives for the treatment of portal hypertension and migraine |
| EP0558824A1 (en) * | 1992-02-04 | 1993-09-08 | Duphar International Research B.V | Method for the preparation of vicinal aminoalcohols and optically active O-protected derivatives thereof |
| JPH05339263A (ja) | 1992-06-08 | 1993-12-21 | Wakunaga Pharmaceut Co Ltd | ジヒドロピリジン誘導体 |
| JPH06298746A (ja) | 1993-04-19 | 1994-10-25 | Showa Denko Kk | 環状イミド酸エステルの製造法 |
| EP0714292A4 (en) * | 1993-06-23 | 1996-10-09 | Cambridge Neuroscience Inc | SIGMA RECEPTOR LIGANDS AND THEIR USE |
| US5387685A (en) * | 1993-07-16 | 1995-02-07 | American Cyanamid Co | MDR reversal agents |
| GB9322976D0 (en) | 1993-11-08 | 1994-01-05 | Pfizer Ltd | Therapeutic agents |
| DE4419246A1 (de) * | 1994-06-01 | 1995-12-07 | Merckle Gmbh | Heteroarylsubstituierte Pyrrolizinverbindungen und deren Anwendung in der Pharmazie |
| DE4419247A1 (de) * | 1994-06-01 | 1995-12-07 | Merckle Gmbh | Sulfonylierte Pyrrolizincarbonsäureamide und deren Anwendung in der Pharmazie |
| DE4419315A1 (de) * | 1994-06-01 | 1995-12-07 | Merckle Gmbh | Heteropyrrolizinverbindungen und deren Anwendung in der Pharmazie |
| DE4427838A1 (de) | 1994-08-05 | 1996-02-08 | Thomae Gmbh Dr K | Kondensierte Azepinderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| DE4429079A1 (de) | 1994-08-17 | 1996-02-22 | Thomae Gmbh Dr K | Cyclische Harnstoffderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| JPH08134048A (ja) | 1994-11-08 | 1996-05-28 | Sumitomo Chem Co Ltd | オキサゾリン類の製造法 |
| DE19510566A1 (de) * | 1995-03-23 | 1996-09-26 | Kali Chemie Pharma Gmbh | Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| GB9508622D0 (en) | 1995-04-28 | 1995-06-14 | Pfizer Ltd | Therapeutic agants |
| US5958543A (en) | 1995-07-07 | 1999-09-28 | Stor Media,Inc. | Micro-texturing for sputtered, thin film magnetic media disks utilizing titanium sputtered in the presence of hydrogen to form micro-texturing |
| JPH0930960A (ja) | 1995-07-18 | 1997-02-04 | Takasago Internatl Corp | 真菌感染症治療剤 |
| JPH0987258A (ja) | 1995-09-28 | 1997-03-31 | Sumitomo Chem Co Ltd | オキサゾリン類、その製造方法およびそれを用いる不斉シクロプロパンカルボン酸類の製造方法 |
| CA2190708A1 (en) | 1995-12-08 | 1997-06-09 | Johannes Aebi | Aminoalkyl substituted benzo-heterocyclic compounds |
| US5892116A (en) | 1996-01-03 | 1999-04-06 | Georgetown University | Gelators |
| US5925651A (en) * | 1996-04-03 | 1999-07-20 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US5691362A (en) | 1996-06-05 | 1997-11-25 | Schering-Plough Corporation | Substituted benzene-fused hetero- and carbocyclics as nuerokinin antagonists |
| JP2001501172A (ja) | 1996-08-15 | 2001-01-30 | スミスクライン・ビーチャム・コーポレイション | Ｉｌ―８レセプターアンタゴニスト |
| EP0973778A1 (en) | 1997-03-07 | 2000-01-26 | Novo Nordisk A/S | 4,5,6,7-TETRAHYDRO-THIENO 3,2-c]PYRIDINE DERIVATIVES, THEIR PREPARATION AND USE |
| AUPP020297A0 (en) | 1997-11-05 | 1997-11-27 | University Of Melbourne, The | A novel receptor, and compounds which bind thereto |
| EP0987235B1 (en) | 1998-08-25 | 2003-03-12 | MERCK PATENT GmbH | Method for the conversion of arenes or alkenes with iodoalkenes, aryl iodides or arenediazonium salts |
| EP1074549B1 (en) | 1999-08-06 | 2003-11-19 | F. Hoffmann-La Roche Ag | Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors |
| ATE254614T1 (de) * | 1999-08-06 | 2003-12-15 | Hoffmann La Roche | Tetrahydro-benzo(d)azepine und deren verwendung als metabotrope glutamatrezeptor-antagonisten |
| DE10003708A1 (de) * | 2000-01-28 | 2001-08-02 | Solvent Innovation Gmbh | Neuartige chirale ionische Flüssigkeiten und Verfahren zu ihrer Darstellung in enantiomerenreiner oder enantiomerenangereicherter Form |
| AR035369A1 (es) | 2000-11-14 | 2004-05-12 | Smithkline Beecham Plc | Derivados de tetrahidrobenzazepina composiciones farmaceuticas que los comprenden, el uso de dichos derivados en la fabricacion de medicamentos, e intermediarios utiles en la preparacion de dichos compuestos |
| GB0030710D0 (en) | 2000-12-15 | 2001-01-31 | Hoffmann La Roche | Piperazine derivatives |
| WO2002074746A1 (en) | 2001-03-16 | 2002-09-26 | Yamanouchi Pharmaceutical Co., Ltd. | Benzazepine derivatives |
| US6825198B2 (en) | 2001-06-21 | 2004-11-30 | Pfizer Inc | 5-HT receptor ligands and uses thereof |
| EP1430032A2 (en) | 2001-09-24 | 2004-06-23 | Elan Pharmaceuticals, Inc. | Substituted amides for the treatment of neurological disorders |
| EP1513522A2 (en) | 2002-01-18 | 2005-03-16 | Sri International | Methods of treating conditions associated with an edg receptor |
| WO2003077847A2 (en) * | 2002-03-12 | 2003-09-25 | Merck & Co., Inc. | Substituted amides |
| US6953787B2 (en) * | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
| GB0224557D0 (en) | 2002-10-22 | 2002-11-27 | Glaxo Group Ltd | Novel compounds |
| WO2005019179A2 (en) | 2003-06-17 | 2005-03-03 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases |
| NZ578503A (en) | 2003-06-17 | 2011-02-25 | Arena Pharm Inc | Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases |
| US20080009478A1 (en) | 2003-10-22 | 2008-01-10 | Arena Pharmaceuticals, Inc. | Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2c Receptor Associated Diseases |
| WO2005042490A1 (en) | 2003-10-22 | 2005-05-12 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
| MX2007001337A (es) | 2004-08-02 | 2008-03-13 | Genmedica Therapeutics Sl | Compuestos para inhibir amina-oxidasas que contienen cobre y usos de los mismos. |
| WO2006043710A1 (ja) | 2004-10-19 | 2006-04-27 | Reverse Proteomics Research Institute Co., Ltd. | 創薬標的タンパク質及び標的遺伝子、並びにスクリーニング方法 |
| WO2006069363A2 (en) | 2004-12-21 | 2006-06-29 | Arena Pharmaceuticals, Inc. | Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride |
| DK1833473T3 (da) | 2004-12-23 | 2010-01-11 | Arena Pharm Inc | 5HT2C-Receptormodulator-sammensætninger og metoder for anvendelse |
| EP2001852A2 (en) | 2006-04-03 | 2008-12-17 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto |
-
2003
- 2003-04-10 US US10/410,991 patent/US6953787B2/en not_active Expired - Lifetime
- 2003-04-11 MX MXPA04009965A patent/MXPA04009965A/es active IP Right Grant
- 2003-04-11 AT AT03718323T patent/ATE294781T1/de active
- 2003-04-11 CA CA002481723A patent/CA2481723C/en not_active Expired - Lifetime
- 2003-04-11 IL IL16416203A patent/IL164162A0/xx unknown
- 2003-04-11 EP EP10010296A patent/EP2363394A1/en not_active Withdrawn
- 2003-04-11 RU RU2004133068/04A patent/RU2317982C2/ru active
- 2003-04-11 EP EP03718323A patent/EP1411881B9/en not_active Expired - Lifetime
- 2003-04-11 MY MYPI20031375A patent/MY141476A/en unknown
- 2003-04-11 SI SI200330049T patent/SI1411881T1/xx unknown
- 2003-04-11 JP JP2003583332A patent/JP4155926B2/ja not_active Expired - Lifetime
- 2003-04-11 NZ NZ535381A patent/NZ535381A/en not_active IP Right Cessation
- 2003-04-11 CN CN200910000191.0A patent/CN101486678B/zh not_active Expired - Lifetime
- 2003-04-11 CN CN2009100001906A patent/CN101486677B/zh not_active Expired - Lifetime
- 2003-04-11 DK DK03718323T patent/DK1411881T3/da active
- 2003-04-11 EP EP10010297.9A patent/EP2374796B1/en not_active Expired - Lifetime
- 2003-04-11 CN CNB038082721A patent/CN100486967C/zh not_active Expired - Lifetime
- 2003-04-11 PL PL391779A patent/PL219017B1/pl unknown
- 2003-04-11 TW TW092108353A patent/TWI252105B/zh not_active IP Right Cessation
- 2003-04-11 BR BRPI0309303A patent/BRPI0309303B8/pt not_active IP Right Cessation
- 2003-04-11 KR KR1020097000060A patent/KR100908167B1/ko not_active Expired - Lifetime
- 2003-04-11 PT PT03718323T patent/PT1411881E/pt unknown
- 2003-04-11 ES ES03718323T patent/ES2242165T3/es not_active Expired - Lifetime
- 2003-04-11 EP EP05002866A patent/EP1557409A1/en not_active Withdrawn
- 2003-04-11 CN CNA200910000193XA patent/CN101485664A/zh not_active Withdrawn
- 2003-04-11 AU AU2003221866A patent/AU2003221866B2/en not_active Expired
- 2003-04-11 DE DE60300610T patent/DE60300610T2/de not_active Expired - Lifetime
- 2003-04-11 PL PL396873A patent/PL231405B1/pl unknown
- 2003-04-11 PL PL373464A patent/PL211314B1/pl unknown
- 2003-04-11 KR KR1020047016198A patent/KR100812925B1/ko not_active Expired - Lifetime
- 2003-04-11 WO PCT/US2003/011076 patent/WO2003086306A2/en not_active Ceased
- 2003-04-11 PL PL391780A patent/PL211333B1/pl unknown
- 2003-04-11 ES ES10010297.9T patent/ES2670568T3/es not_active Expired - Lifetime
- 2003-04-11 KR KR1020087000551A patent/KR100908166B1/ko not_active Expired - Lifetime
- 2003-04-11 CN CNA2009100001925A patent/CN101486679A/zh active Pending
- 2003-04-11 BR BR122017023795A patent/BR122017023795B8/pt not_active IP Right Cessation
- 2003-11-04 UA UA20041109253A patent/UA77788C2/uk unknown
-
2004
- 2004-08-13 US US10/917,979 patent/US7514422B2/en not_active Expired - Lifetime
- 2004-09-28 CR CR7503A patent/CR7503A/es unknown
- 2004-10-06 IS IS7490A patent/IS2134B/xx unknown
- 2004-10-20 ZA ZA200408506A patent/ZA200408506B/en unknown
- 2004-11-11 NO NO20044928A patent/NO323528B1/no not_active IP Right Cessation
-
2006
- 2006-03-03 JP JP2006058747A patent/JP4191741B2/ja not_active Expired - Lifetime
- 2006-11-14 US US11/599,050 patent/US7977329B2/en not_active Expired - Fee Related
-
2007
- 2007-02-15 GE GEAP20079867A patent/GEP20074197B/en unknown
-
2008
- 2008-08-05 JP JP2008202412A patent/JP4966929B2/ja not_active Expired - Lifetime
- 2008-10-22 CR CR10393A patent/CR10393A/es not_active Application Discontinuation
-
2011
- 2011-05-27 US US13/118,126 patent/US8207158B2/en not_active Expired - Fee Related
- 2011-09-14 JP JP2011201117A patent/JP5602116B2/ja not_active Expired - Lifetime
-
2012
- 2012-06-14 US US13/523,805 patent/US8273734B1/en not_active Expired - Fee Related
- 2012-09-14 US US13/620,204 patent/US8575149B2/en not_active Expired - Fee Related
- 2012-09-14 US US13/617,072 patent/US8546379B2/en not_active Expired - Fee Related
- 2012-09-14 US US13/616,981 patent/US8846906B2/en not_active Expired - Lifetime
- 2012-09-25 JP JP2012211059A patent/JP2013018780A/ja not_active Withdrawn
-
2014
- 2014-07-09 US US14/326,977 patent/US8993750B2/en not_active Expired - Lifetime
-
2015
- 2015-02-23 US US14/629,083 patent/US20160024014A1/en not_active Abandoned
-
2016
- 2016-05-12 US US15/152,648 patent/US20160250223A1/en not_active Abandoned